CREDIT SUISSE AG/ - ACELRX PHARMACEUTICALS INC ownership

ACELRX PHARMACEUTICALS INC's ticker is ACRX and the CUSIP is 00444T100. A total of 78 filers reported holding ACELRX PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 1.18 and the average weighting 0.0%.

Quarter-by-quarter ownership
CREDIT SUISSE AG/ ownership history of ACELRX PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2021$26,000
-16.1%
15,649
-36.7%
0.00%
Q4 2020$31,000
-26.2%
24,724
+29.7%
0.00%
Q3 2019$42,000
-33.3%
19,058
-23.9%
0.00%
Q2 2019$63,000
+34.0%
25,055
+78.9%
0.00%
Q2 2018$47,000
+62.1%
14,008
+0.0%
0.00%
Q1 2018$29,000
+3.6%
14,002
-0.0%
0.00%
Q4 2017$28,000
-40.4%
14,009
-21.7%
0.00%
Q4 2016$47,000
-9.6%
17,892
+34.4%
0.00%
Q3 2016$52,000
-65.1%
13,313
-75.9%
0.00%
Q2 2016$149,000
-20.3%
55,291
-9.0%
0.00%
Q1 2016$187,000
-43.2%
60,786
-29.1%
0.00%
Q4 2015$329,000
+813.9%
85,676
+620.8%
0.00%
Q3 2015$36,000
-95.6%
11,887
-93.9%
0.00%
-100.0%
Q2 2015$827,000
+55.7%
195,053
+41.8%
0.00%0.0%
Q1 2015$531,000
-16.1%
137,591
+46.2%
0.00%0.0%
Q4 2014$633,000
+333.6%
94,091
+252.4%
0.00%
Q3 2014$146,000
-75.9%
26,700
-54.7%
0.00%
Q2 2014$605,000
+9.2%
58,999
+27.9%
0.00%
-100.0%
Q1 2014$554,000
+36.5%
46,130
+28.5%
0.00%
Q4 2013$406,000
-55.1%
35,910
-57.2%
0.00%
-100.0%
Q3 2013$904,000
+159.8%
83,884
+123.3%
0.00%
Q2 2013$348,000
+140.0%
37,564
+33.9%
0.00%
Q1 2013$145,00028,0510.00%
Other shareholders
ACELRX PHARMACEUTICALS INC shareholders Q4 2020
NameSharesValueWeighting ↓
Perceptive Advisors 3,731,342$8,022,0000.40%
WealthTrust Axiom LLC 210,000$451,0000.17%
Palo Alto Investors LP 1,032,715$2,220,0000.10%
ELEMENT CAPITAL MANAGEMENT LLC 144,536$311,0000.06%
SHEPHERD KAPLAN KROCHUK, LLC 49,761$107,0000.06%
Joel Isaacson & Co., LLC 70,660$152,0000.03%
LMR Partners LLP 148,309$319,0000.02%
LINCOLN CAPITAL CORP 10,000$22,0000.02%
Malaga Cove Capital, LLC 13,150$28,0000.02%
Cornerstone Capital, Inc. 30,000$65,0000.01%
View complete list of ACELRX PHARMACEUTICALS INC shareholders